Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

NCT00042458 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Pramlintide acetate
DRUG: Placebo

Sponsor

AstraZeneca